Document is current
Any future updates will be listed below
-
Authors
Schenk, Hannah
Holle, Dagny
Nsaka, Michael
Kleinschnitz, Christoph
Glas, Martin
Scheffler, Armin
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 28 March 2022
Accepted: 30 April 2022
First Online: 11 May 2022
Declarations
:
: The analysis was approved by the independent ethics committee of the University Hospital Essen (19-9004-BO) and all patients gave written consent to general analysis of their personal and clinical data.
: Not applicable.
: Dagny Holle has received scientific support and/or honoraria from Biogen, Novartis, Lilly, Sanofi-Aventis, Teva, Allergan, Hormosan.Christoph Kleinschnitz has received honoraria, a consulting or advisory role to declare from Novartis and Teva.Martin Glas received honoraria from Novartis, UCB, Teva, Bayer, Novocure, Medac, Merck, Kyowa Kirin, has a consulting or advisory role to declare for Roche, Novartis, AbbVie, Novocure, and Daiichi Synkyo, and received travel fees from Novocure and Medac.Michael Nsaka received travel fees from Licher MT.Armin Scheffler received travel fees from Teva and honoraria for participation on an advisory board of Novartis.Hannah Schenk declares that there is no conflict of interest.
